story of the week
Activity of Cabozantinib After Immune Checkpoint Blockade in Metastatic Clear Cell Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Cancer
Activity of Cabozantinib After Immune Checkpoint Blockade in Metastatic Clear-Cell Renal Cell Carcinoma
Eur. J. Cancer 2020 Aug 01;135(xx)203-210, BA McGregor, A-K A Lalani, W Xie, et alRenal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.